Latest Insider Transactions at Trans Medics Group, Inc. (TMDX)
This section provides a real-time view of insider transactions for Trans Medics Group, Inc. (TMDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TransMedics Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TransMedics Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2021
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
8,600
-22.53%
|
$283,800
$33.48 P/Share
|
|
Feb 09
2021
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
8,600
+30.68%
|
$0
$0.28 P/Share
|
|
Feb 09
2021
|
James R Tobin |
SELL
Open market or private sale
|
Indirect |
10,168
-1.17%
|
$335,544
$33.49 P/Share
|
|
Feb 09
2021
|
Abrams Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
786,664
-23.06%
|
$25,959,912
$33.32 P/Share
|
|
Feb 08
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$250,000
$25.01 P/Share
|
|
Feb 08
2021
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,429
+50.0%
|
$0
$0.67 P/Share
|
|
Feb 08
2021
|
Abrams Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
88,483
-2.53%
|
$2,300,558
$26.24 P/Share
|
|
Jan 19
2021
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
9,617
-47.04%
|
$211,574
$22.12 P/Share
|
|
Jan 19
2021
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
9,617
+31.99%
|
$0
$0.39 P/Share
|
|
Jan 05
2021
|
Waleed H Hassanein President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
123,414
+26.7%
|
$0
$0.39 P/Share
|
|
Jan 04
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,184
-12.39%
|
$23,680
$20.0 P/Share
|
|
Dec 31
2020
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,816
-47.47%
|
$176,320
$20.0 P/Share
|
|
Dec 21
2020
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
1,000
-8.45%
|
$17,000
$17.99 P/Share
|
|
Dec 16
2020
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+7.8%
|
$0
$0.39 P/Share
|
|
Dec 15
2020
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
3,000
-21.7%
|
$48,000
$16.63 P/Share
|
|
Dec 15
2020
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+17.83%
|
$0
$0.39 P/Share
|
|
Dec 11
2020
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+50.0%
|
$13,800
$3.22 P/Share
|
|
Oct 29
2019
|
Flagship Ventures Fund Iv General Partner LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,840,191
-100.0%
|
-
|
|
May 06
2019
|
Abrams Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,499,859
+50.0%
|
-
|
|
May 06
2019
|
Flagship Ventures Fund Iv General Partner LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,047,254
+44.41%
|
-
|
|
May 06
2019
|
Flagship Ventures Fund Iv General Partner LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
483,021
+50.0%
|
-
|
|
May 06
2019
|
Flagship Ventures Fund Iv General Partner LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,690,579
-100.0%
|
-
|